Concepedia

Kai Juhani Kauppinen

KJ

Statistics

Publications

2

Citations

87

H-Index

2

Active since

2019

Affiliations

University of Helsinki(Current)

Kai Juhani Kauppinen is an author at University of Helsinki specializing in lipid profile effects, lipid-lowering therapy, and tenofovir therapy.

ORCID

Publications per year

2019–2022

2

Publications

2

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

Kai Juhani Kauppinen, Pia Kivelä, Jussi Sutinen · AIDS Patient Care and STDs · 2019 · 50 citations

, , +14

Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain

Kai Juhani Kauppinen, Inka Aho, Jussi Sutinen · AIDS · 2022 · 37 citations · Full text

, , +17

1–2 of 2